Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.6959
-$0.0241-3.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.46% | 33.09% | 26.27% | 32.87% | -8.49% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,084.96% | 74.58% | 30.48% | -94.84% | -315.59% |
| Change in Net Operating Assets | 37.71% | -2,297.68% | -22.33% | -123.39% | -268.84% |
| Cash from Operations | 30.12% | -2.52% | 31.36% | -59.41% | -47.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -37.83% |
| Total Debt Repaid | -181.81% | 16.04% | -- | 72.02% | -- |
| Issuance of Common Stock | -- | -39.47% | -- | -50.42% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.80% | -37.60% | -- | -48.58% | -51.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.15% | -56.96% | 89.98% | -5,472.60% | -56.85% |